相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Focal adhesion signaling and therapy resistance in cancer
Iris Eke et al.
SEMINARS IN CANCER BIOLOGY (2015)
YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells
S. M. Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells
Anne-Marie Ray et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis
Ju Liu et al.
CELL DEATH AND DIFFERENTIATION (2014)
Integrated high-throughput analysis identifies Sp1 as a crucial determinant of p53-mediated apoptosis
H. Li et al.
CELL DEATH AND DIFFERENTIATION (2014)
Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage
H-H Zhang et al.
CELL DEATH AND DIFFERENTIATION (2014)
sROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
Y. Shi et al.
CELL DEATH AND DIFFERENTIATION (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Survivin as a Preferential Target for Cancer Therapy
Mahsa Mobahat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity
J. Viotti et al.
ONCOGENE (2014)
Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance
P. Dahan et al.
CELL DEATH & DISEASE (2014)
Selective Imaging of the Angiogenic Relevant Integrins α5β1 and αvβ3
Stefanie Neubauer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas
Verena Funke et al.
CANCER LETTERS (2013)
Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells
Hana Janouskova et al.
CANCER LETTERS (2013)
Survivin promotion of melanoma metastasis requires upregulation of α5 integrin
Jodi A. McKenzie et al.
CARCINOGENESIS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis
Y-C Chen et al.
CELL DEATH AND DIFFERENTIATION (2013)
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis
M. Kracikova et al.
CELL DEATH AND DIFFERENTIATION (2013)
Impairment of Glioma Stem Cell Survival and Growth by a Novel Inhibitor for Survivin-Ran Protein Complex
Hacer Guvenc et al.
CLINICAL CANCER RESEARCH (2013)
Radiation-induced mitotic cell death and glioblastoma radioresistance: A new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1alpha and survivin in U87 cells
Olivia Lanvin et al.
EUROPEAN JOURNAL OF CANCER (2013)
β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments
Herbert B. Schiller et al.
NATURE CELL BIOLOGY (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
Florence Schaffner et al.
Cancers (2013)
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
James G. Jackson et al.
CANCER CELL (2012)
Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
Hana Janouskova et al.
CANCER RESEARCH (2012)
Chk2 mediates RITA-induced apoptosis
J. de Lange et al.
CELL DEATH AND DIFFERENTIATION (2012)
Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy
Michael Delay et al.
CLINICAL CANCER RESEARCH (2012)
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network
Kristen M. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Integrins as therapeutic targets
Simon L. Goodman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Targeting survivin in cancer: the cell-signalling perspective
Jagat R. Kanwar et al.
DRUG DISCOVERY TODAY (2011)
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
Sandy Hendruschk et al.
NEURO-ONCOLOGY (2011)
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
A. K. Mitra et al.
ONCOGENE (2011)
Activation of p53 by Nutlin-3a Induces Apoptosis and Cellular Senescence in Human Glioblastoma Multiforme
Ruth Villalonga-Planells et al.
PLOS ONE (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation
Jodi A. McKenzie et al.
CANCER RESEARCH (2010)
Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin α5β1 and Fibronectin
Jin-Min Nam et al.
CANCER RESEARCH (2010)
Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
Benito Campos et al.
CLINICAL CANCER RESEARCH (2010)
α5β1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells
Eva Martinkova et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis
Yosuke Watanabe et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer
Anne-Marie C. Dingemans et al.
MOLECULAR CANCER (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
Vera V. Grinkevich et al.
CANCER CELL (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data
Lawrence P. Petalidis et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway
A. Eckert et al.
ONCOGENE (2008)
Integrins in angiogenesis and lymphangiogenesis
Christie J. Avraamides et al.
NATURE REVIEWS CANCER (2008)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase
P. S. Hodkinson et al.
CELL DEATH AND DIFFERENTIATION (2006)
Strategies for therapeutic targeting of the p53 pathway in cancer
K. G. Wiman
CELL DEATH AND DIFFERENTIATION (2006)
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction
A Eramo et al.
CANCER RESEARCH (2005)
PED mediates AKT-dependent chemoresistance in human breast cancer cells
G Stassi et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
FLICE/caspase-8 activation triggers anoikis induced by β1-integrin blockade in human keratinocytes
A Marconi et al.
JOURNAL OF CELL SCIENCE (2004)
PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation
FL Chou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fibronectin protects prostate cancer cells from tumor necrosis factor-α-induced apoptosis via the AKT/survivin pathway
M Fornaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action
A Trencia et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Expression of survivin in astrocytic tumors - Correlation with malignant grade and prognosis
Y Kajiwara et al.
CANCER (2003)
Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function
G Condorelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
